| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Director | Director, 10% Owner
3 companies
Haurwitz Rachel E. is a Director, 10% Owner at NTLA with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $84.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | CRBU Caribou Biosciences, Inc. | President And CEO | Buy | 20,000 | $1.02 | $20,400.00 | +0.6% | +14.9% | +86.1% |